Previous 10 | Next 10 |
INOVIO Reports Positive Phase 1b Results for INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) PR Newswire INO-4201 found to be well-tolerated in the trial Humoral responses were boosted in 100% (36 of 36) of treated participants PLYMOUTH MEETING, Pa. ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pharmaceutical stocks have been relatively subdued in the last 12 months. During this period, the S&P 500 Pharmaceutical Industry index has trended higher by 3.5%. I believe there are undervalued stocks in the sector po...
Inovio ( NASDAQ: INO ) will undergo a strategic reorganization that is expected to save the biotech $4.3M annually and will result in an 11% reduction in its staff. The company said the changes are need to advance its key assets, especially lead program INO-3107 for Recurrent Respirat...
INOVIO Announces Strategic Reorganization, Continues Efforts to Focus on Promising DNA Medicine Candidates PR Newswire Cost-saving measures include 11% headcount reduction Annual savings expected to be approximately $4.3 million Data readouts expected in first quar...
Summary Inovio’s stock price is near multi-year lows. It was unable to bring a COVID vaccine to market. It has a viable path to FDA approval for precancers caused by HPV. Inovio ( INO ) seems to be a perpetually clinical phase biotechnology company. The stock pr...
INOVIO Provides an Update on Lassa Fever and MERS Programs PR Newswire PLYMOUTH MEETING, Pa. , Nov. 17, 2022 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prevent in...
One way to get through downturns is to focus on the future. Equities won't stay down forever; in fact, bull markets tend to last far longer than bear markets. That means there will be plenty of time to recoup losses incurred during this period -- but only if you pick the right stocks. C...
Palm Beach, FL – November 16, 2022 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic has devastated the world and impacted millions of people… as a result, the demand for the creation of therapeutic treatments has increased due to the p...
3 Factors to Consider When Buying Biotech Penny Stocks Penny stocks in the biotech sector can be a great way to make money in the stock market. While these stocks are often overlooked by major investors, they can offer huge returns if you know what to look for. Here are three reasons wh...
Shares of small-cap biotech Inovio Pharmaceuticals ( NASDAQ: INO ) gained as much as 14.3% to $2.45 in Wednesday afternoon trading, after it reported a Q3 profit beat and extended its cash runway projections. The gains continue a recent strong run for the stock, which is...
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLYMOUTH MEETING, Pa. , July 25, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and ...
5G leader welcomes new Chief Product Officer, Senior Vice President Sales/Service Providers and Head of Operations Inseego Corp. (Nasdaq: INSG), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises, and SMBs, today announced...
2024-07-16 13:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...